ThinkGenetic announces its participation at the 2023 ACMG Annual Clinical Genetics Meeting which is being held in conjunction with the Society for Inherited Metabolic Disorders Meeting for the first time in Salt Lake City, Utah, this March.
ThinkGenetic Announces Participation at 19th Annual WORLDSymposium™ 2023
ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited.
Extracting Electronic Health Record (EHR) Data Using Transfer Learning
At ThinkGenetic, Inc. our goal is to reduce the time to diagnosis for genetic and rare conditions. Given they are rare, we must be cognizant of the time it takes […]
[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer
Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
Supporting Rare Disease Day 2022
February 28th is Rare Disease Day! In the United States, a disease is defined as rare if it affects less than 200,000 people. It is currently thought that there may be […]
